Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,
Hepatitis B is inflammation of the liver caused by infection with the hepatitis B virus. This highly contagious virus is spread through exposure to bodily fluids infected with the virus including blood, semen, breast milk, vaginal secretions and saliva.
The hepatitis B virus is between 50 and 100 times more infectious than HIV and can also survive outside of the body for at least a week, meaning surfaces or objects contaminated with dried blood, for example, can also pose a risk.
Hepatitis B is the most common form of hepatitis found worldwide, although it is uncommon in the U.K. Regions where incidence of this condition is higher include Asia, sub-Saharan Africa, the Middle East, and southern Europe. In the inner cities of these regions, up to one in 60 pregnant women may be infected with the virus.
The incubation period of hepatitis B is 22 weeks, during which time infected individuals may present with few or no symptoms. However, these individuals are still contagious and capable of unknowingly transmitting the virus to others.
The symptoms caused by hepatitis B range in severity from mild to life threatening. The illness can occur as either an acute or chronic disease. Acute hepatitis B is a short-term illness that occurs within six months of exposure to the virus and is usually cleared by adults within three months (in 90% of cases). Individuals who recover also develop antibodies against any future hepatitis B infection.
Infants, on the other hand, are less resilient to hepatitis B because their immune systems do not launch an attack against the virus that is vigorous enough to clear it. In 90% of cases, infected infants go on to develop the chronic form of hepatitis B. By contrast, only 6 to 10% of children older than five years go on to develop chronic illness. Up to one in ten adults who become infected with hepatitis B also go on to develop chronic disease.
Not all individuals infected with the hepatitis B virus develop the symptoms of acute hepatitis, with around 30% of those infected staying symptom-free. In cases where symptoms do develop, they occur between 40 and 160 days after infection and tend to pass within three months. These early symptoms are non-specific and include the following:
Sometimes, the symptoms of acute hepatitis B can be more severe and the patient requires hospitalization. Examples of more severe symptoms include:
In rare cases, the liver damage caused by acute hepatitis is so severe that the organ can no longer function. This fatal condition is referred to as “fulminant hepatitis” and can lead to severe bleeding disorders and coma. Patients suffering from this condition are usually evaluated for liver transplantation.
In cases where the immune system fails to control hepatitis B within six months, an individual is said to have chronic hepatitis B. Again, not everyone with the chronic form of this disease develops symptoms. The liver plays a key role in many vital bodily functions, including immunity, coagulation, digestion and metabolism. Symptoms therefore vary widely depending on how severe the liver damage is and how much dysfunction has been caused.
Individuals with chronic hepatitis B can remain symptom-free for many years or even decades. However, in some cases, inflammation of the liver can cause severe scarring of the organ referred to as cirrhosis, which can eventually lead to liver dysfunction. Some of the symptoms that suggest cirrhosis may have developed include:
In cases of advanced cirrhosis, liver failure can occur, which may lead to the following life-threatening complications:
Individuals with chronic hepatitis B are at an increased risk of developing liver cancer. The symptoms are non-specific and again range in severity. Some patients have no symptoms; some experience inflammation and pain; while others may experience fever and weight loss.
The condition is diagnosed using an ultrasound scan of the liver and a blood test to check for alpha-fetoprotein, which is produced in cases of liver cancer. Patients who have chronic hepatitis B are screened using these two tests, particularly if they have developed cirrhosis or have a family history of liver cancer.